Qingdao Haier Biomedical Co Ltd (688139) — Cash Flow Quality Index
Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow Quality Index of 0.05x as of June 2023. Operating cash flow of CN¥7.33 Million is below net income of CN¥140.93 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Qingdao Haier Biomedical Co Ltd (688139) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Qingdao Haier Biomedical Co Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Qingdao Haier Biomedical Co Ltd.
Annual Cash Flow Quality Index for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year earnings quality comparison for Qingdao Haier Biomedical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.07x | CN¥267.89 Million | CN¥250.73 Million | ▲ +34.3% |
| 2024 | 0.80x | CN¥291.67 Million | CN¥366.63 Million | ▲ +29.6% |
| 2023 | 0.61x | CN¥249.26 Million | CN¥406.07 Million | ▼ -41.7% |
| 2022 | 1.05x | CN¥632.43 Million | CN¥600.79 Million | ▲ +36.2% |
| 2021 | 0.77x | CN¥632.43 Million | CN¥818.33 Million | ▼ -57.7% |
| 2020 | 1.83x | CN¥696.62 Million | CN¥380.95 Million | ▲ +18.7% |
| 2019 | 1.54x | CN¥280.49 Million | CN¥182.06 Million | ▲ +17.8% |
| 2018 | 1.31x | CN¥149.00 Million | CN¥113.96 Million | ▼ -46.8% |
| 2017 | 2.46x | CN¥148.32 Million | CN¥60.39 Million | ▲ +37.1% |
| 2016 | 1.79x | CN¥220.72 Million | CN¥123.21 Million | — |